Long-acting injectable CAB/RPV_SUPLA W52

Published: 14 April 2026| Version 1 | DOI: 10.17632/56jcsy3fbn.1
Contributor:
Nan-Yu Chen

Description

LA_W52.csv: HIV-1 RNA levels through Week 52 for Group 1 (Immediate LA) and Group 2 (Delayed switch). Data handling for analysis: ND was calculated as 0; <20 as 19; <40 as 39. Fig2.R: R script for reproducing Figure 2 in the manuscript.

Files

Institutions

Categories

Clinical Trial, Human Immunodeficiency Virus, Therapeutic Management in Adherence

Funders

Licence